3351 Results

People

  1. Kris
    Kris
  2. Drilon
    Drilon
  3. Riely
    Riely
  4. Rudin
    Rudin
  5. Ladanyi
    Ladanyi
  6. Hellmann
    Hellmann
  7. Yu
    Yu
  8. Paik
    Paik
  9. Rusch
    Rusch
  10. Rekhtman
    Rekhtman

Groups

  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (593)
  8. Weinberg Fellows (537)
  9. Sloan Kettering Institute Postdocs (491)
  10. Tow Center for Developmental Oncology (TCDO) (471)
  1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Bronchioloalveolar carcinoma of the lung
    Book Section

    Riely, G. J.; Miller, V. A.
    In Raghavan, D.; Brecher, M. L.; Johnson, D. H.; Meropol, N. J.; Moots, P. L.; Rose, P. G.; Mayer, I. A. (Eds.) Textbook of Uncommon Cancer. 3rd ed (2006)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
    Meeting Abstract

    Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase I/II study of ABI-007 as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Rizvi, N. A.; Azzoli, C.; Miller, V.; Ng, K.; Fiore, J.; Chia, G.; Brower, M.; Heelan, R.; Hawkins, M.; Kris, M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G ("acquired resistance") followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)
    Meeting Abstract

    Riely, G. J.; Kris, M. G.; Schwartz, L. H.; Akhurst, T.; Zhao, B.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Miller, V. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Molecular analysis of NSCLC patients with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Pao, W.; Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • EGFR mutation and copy number, EGFR protein expression and KRAS mutation as predictors of outcome with erlotinib in bronchioloalveolar cell carcinoma (BAC): Results of a prospective phase II trial
    Meeting Abstract

    Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Ladanyi, M.; Tsao, A. S.; Sandler, A.; Herbst, R.; Kris, M. G.; Johnson, D. H.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type
    Meeting Abstract

    Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type
    Meeting Abstract

    Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • Prospective trial with preoperative gefitinib to correlate lung cancer response with EGFR exon 19 and 21 mutations and to select patients for adjuvant therapy
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, M. F.; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save